Percutaneous transluminal angioplasty increases thromboxane A2 production in claudicants
- 1 May 1997
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 56 (5) , 369-372
- https://doi.org/10.1016/s0952-3278(97)90585-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Prostacyclin and thromboxane biosynthesis in mild essential hypertension.Hypertension, 1990
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988
- Thromboxane and prostacyclin formation in patients with deep vein thrombosisThrombosis Research, 1987
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- On the Formation and Effects of Thromboxane A2 in Human PlateletsActa Physiologica Scandinavica, 1976
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976